"After Brain-Computer Interfaces, Before the Future" Event Registration | October 30: Meet the People Building Tomorrow

道彤投资·October 14, 2026·0·3

Brain signals are controlling robotic arms, ultrasound is being used to probe the brain, and flexible neural electrodes are inching closer to real clinical applications...

EEG signals are controlling robotic arms. Ultrasound is being used to explore the brain. Flexible neural electrodes are inching closer to real clinical applications...

These aren't distant sci-fi fantasies. They're happening right now.

By 2026, brain-computer interfaces (BCI) are moving from the lab into clinics and industry. But it's still early days — too many questions remain unanswered.

For instance:

Where will different technical approaches lead?

Which step from lab to commercialization is most likely to kill a startup halfway?

As machines begin to understand and connect with the brain more deeply, how will the relationship between humans and technology change?

There are no definitive answers yet. So we want to bring together the people searching for them.

SEF EVENTS × Tong Academy

Beyond BCI, Before Tomorrow

Date: Friday, October 30, 2026, 15:00–18:00
Location: Shanghai (exact address provided after registration approval)
Co-organizers: Shanghai Future Industry Fund, Shanghai Future Origin Community, Dalton Venture

This event brings together the people building BCIs, the people investing in them, and the people who simply want to talk about them.

Tong Academy is Dalton Venture's post-investment event IP, designed to build a platform connecting portfolio companies, research institutions, industry partners, and investors — fostering innovation resource connections and industrial collaboration.

Who You'll Meet

Founders turning BCI concepts into products

Ultrasound-based BCIs, motor rehabilitation, speech decoding, neuromodulation... different technical approaches, on the same stage

Industry players and investors watching the next human-machine interface

Dalton Venture will share what we've seen, thought through, and invested in across the BCI landscape

Plus BCI scientists, clinicians, and industry professionals

Speaker Preview

More to be announced

Weifan Wei

General Manager, Shanghai Future Industry Fund

Chairman, Shanghai Future Origin Community

Shanghai Future Origin Community is a sci-tech innovation ecosystem platform launched in July 2025. Centered on "talent + cognition," it serves as a hub for top-tier talent and cutting-edge knowledge exchange, aiming to become the preferred destination for world-class entrepreneurs and a core infrastructure for talent development and cognitive upgrading in Shanghai's future industries.

Qi Sun

Founding Managing Partner, Dalton Venture

Founded in 2015, Dalton Venture is a venture capital firm focused on early-to-mid-stage investments and industrial M&A in life sciences, with roots extending into hard tech opportunities. Under the brand ethos "rooted in life sciences, growing toward hard tech," Dalton has deployed across seven representative BCI companies covering the full spectrum: non-invasive/invasive, medical/industrial, hardware/software, and diagnostics/therapeutics.

Lei Peng

Founder & CEO, Gestalt Technology

Gestalt Technology (Gestala) is China's first life sciences company focused on the ultrasound pathway for brain-computer interfaces. With the vision "Better Brain for Better Humanity," it is building an ultrasound-based BCI platform with whole-brain read-write capability — not only delivering innovative treatments for neurological disorders, but also decoding the brain to explore the future convergence of neuroscience and artificial intelligence.

Chengyu Li

Chief Advisor, Zhudong Technology SAB

Chief Scientist of Brain-Computer Interfaces, Lingang Laboratory

Zhudong Technology is a leading invasive BCI platform company, a commercial spin-off from Lingang Laboratory. It focuses on R&D, manufacturing, and clinical application of invasive BCIs. The company has built a full-stack technical system covering flexible electrodes, chips, packaging, wireless communication, high-frequency wireless charging, AI regulation algorithms, and data platforms, with core supply chains under independent control.

Guojia Wu

CEO, Zhudong Technology

Ximing Wang

Co-founder, Kongshanci

Founded in October 2024, Kongshanci specializes in affective and cognitive brain-computer interfaces, dedicated to transforming the diagnosis and treatment paradigm for psychiatric and cognitive disorders. Its core technical approach centers on advanced cognitive function decoding and closed-loop neuromodulation, integrating fMRI, EEG, and ultrasound signals with energy modalities including transcranial magnetic stimulation (TMS), temporal interference (TI), and transcranial focused ultrasound (tFUS) — enabling personalized, spatiotemporally precise closed-loop non-invasive neuromodulation from cortex to deep brain.

Ran Wang

Founder, BrainTalk Technology

BrainTalk Technology is dedicated to core BCI algorithm R&D. The team's core member, Dr. Ran Wang, holds degrees from Tsinghua University and New York University, and was a postdoctoral researcher at UCSF and NYU. The team brings together talent from Tsinghua University, New York University, UCSF, and Nanjing University, focusing on BCI decoding algorithms and language rehabilitation.

Zaixi Tang

Founder, HuaBrain Security

HuaBrain Security (Beijing) Technology Co., Ltd. is the supporting entity for the Ministry of Emergency Management's Key Laboratory of Brain-Computer Interface, and the only domestic company with a complete industrial BCI technology system. It is the global pioneer in applying BCI technology to complex industrial scenarios including mining, infrastructure, power, metallurgy, and petrochemicals, and has launched the world's first BCI safety monitoring product certified with coal safety marks.

Yun Zhao

Founder, New Cloud Medical

Founded in 2016, New Cloud Medical is an innovative medical device company focused on full-cycle pain management, grounded in neuroscience and driven by brain-computer interface and AI core technologies, committed to providing products and services that free humanity from pain. The company is a nationally certified high-tech enterprise and Beijing innovative SME, deeply involved in drafting domestic neuro-medical device industry standards, with complete R&D, manufacturing, and sales capabilities.

Fen Chen

Founder, Macroweave Innovation

Macroweave Innovation Medical Technology (Shanghai) Co., Ltd. is an innovative medical enterprise focused on neuromodulation and intelligent brain-computer interfaces, integrating neural engineering, AI algorithms, and wearable hardware. With peripheral neuromodulation at its core, its first wearable nerve stimulator has entered clinical trials for hand tremor treatment in essential tremor and Parkinson's disease. The company is also developing products for epilepsy monitoring and warning, sleep neural rhythm assessment, and transcutaneous auricular vagus nerve stimulation, building a "real-time monitoring — intelligent warning — active regulation" system.

Swipe to view more

What We'll Discuss

This isn't a show-up-and-leave industry forum.

BCI founders across different technical approaches will take the stage to talk real problems from the front lines, such as:

Where's the boundary between invasive and non-invasive?

What's still missing for BCIs to truly enter clinical practice?

Which step from research to product is hardest to cross?

What future are BCI entrepreneurs betting on?

If you:

Are building or researching BCI, neuroscience, or neural materials
Want to start a company but are still watching, and need a chance to "exchange glances" with peers
Are simply curious about BCIs and want to hear what people on the ground are thinking

🌟 Fill out the registration form — we look forward to meeting you in person!

Beyond BCI, Before Tomorrow

脑机之后，未来之前

October 30 · Shanghai

Scan the QR code to register

Registration deadline: October 23

(Detailed venue information provided after approval)

Before tomorrow, let's meet